We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002916:SZSEShennan Circuit Co., Ltd. Class A Analysis

Data as of 2026-05-26 - not real-time

CN¥419.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Shennan Circuits is trading at a lofty CNY 419.5, well above its 20‑day SMA of 336.9 and the 30‑day DCF fair value of 123, indicating a pronounced overvaluation. The stock shows a bullish technical picture – RSI is soaring at 80.9, MACD is bullish with a positive histogram, and volume is on an increasing trend – but the extreme overbought signal and a downside potential of roughly ‑19% temper enthusiasm. Fundamentals reveal robust top‑line growth of 38% YoY, healthy gross and operating margins (28% and 17% respectively), and a solid ROE near 22%, yet the price‑to‑earnings ratio of 80 dwarfs the industry average of 39.5. Cash generation is mixed: operating cash flow is positive, but free cash flow is negative, raising questions about the sustainability of the modest 0.6% dividend yield despite a low payout ratio of 22%. The market sentiment is at an “Extreme Greed” level (91.6 on the Fear & Greed Index), which, combined with a high 30‑day volatility of 56.7% and a beta below 1, suggests that price swings could be sharp in the near term.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Current price far exceeds DCF fair value
  • RSI in overbought territory
  • Negative free cash flow despite strong earnings

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained revenue growth and solid margins
  • Bullish technical momentum but valuation gap persists
  • Improving cash conversion trends

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong ROE and industry positioning in high‑tech components
  • Potential for valuation correction aligning price with fundamentals
  • Moderate dividend yield with low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth37.90%
Profit Margin14.28%
P/E Ratio80.1
ROE21.87%
ROA8.41%
Debt/Equity21.30
P/B Ratio15.8
Op. Cash FlowCN¥3.5B
Free Cash FlowCN¥-552560448
Industry P/E39.5

Technical Analysis

TrendBullish
RSI80.9
SupportCN¥293.45
ResistanceCN¥432.99
MA 20CN¥336.89
MA 50CN¥286.36
MA 200CN¥227.03
MACDBullish
VolumeIncreasing
Fear & Greed Index91.64

Valuation

Fair ValueCN¥122.97
Target PriceCN¥338.69
Upside/Downside-19.26%
GradeOvervalued
TypeGrowth
Dividend Yield0.60%

Risk Assessment

Beta0.75
Volatility56.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.